Innospec Net Worth

Innospec Net Worth Breakdown

  IOSP
The net worth of Innospec is the difference between its total assets and liabilities. Innospec's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Innospec's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Innospec's net worth can be used as a measure of its financial health and stability which can help investors to decide if Innospec is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Innospec stock.

Innospec Net Worth Analysis

Innospec's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Innospec's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Innospec's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Innospec's net worth analysis. One common approach is to calculate Innospec's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Innospec's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Innospec's net worth. This approach calculates the present value of Innospec's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Innospec's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Innospec's net worth. This involves comparing Innospec's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Innospec's net worth relative to its peers.

Enterprise Value

1.74 Billion

To determine if Innospec is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Innospec's net worth research are outlined below:
Innospec generated a negative expected return over the last 90 days
Over 99.0% of the company shares are owned by institutional investors
On 30th of May 2025 Innospec paid $ 0.84 per share dividend to its current shareholders
Latest headline from finance.yahoo.com: Shareholders in Innospec are in the red if they invested a year ago

Innospec Quarterly Good Will

388.4 Million

Innospec uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Innospec. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Innospec's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
13th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
13th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Innospec Target Price Consensus

Innospec target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Innospec's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   2  Strong Buy
Most Innospec analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Innospec stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Innospec, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Innospec Target Price Projection

Innospec's current and average target prices are 83.87 and 115.00, respectively. The current price of Innospec is the price at which Innospec is currently trading. On the other hand, Innospec's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Innospec Market Quote on 21st of July 2025

Low Price82.81Odds
High Price85.71Odds

83.87

Target Price

Analyst Consensus On Innospec Target Price

Low Estimate104.65Odds
High Estimate127.65Odds

115.0

Historical Lowest Forecast  104.65 Target Price  115.0 Highest Forecast  127.65
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Innospec and the information provided on this page.

Know Innospec's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Innospec is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Innospec backward and forwards among themselves. Innospec's institutional investor refers to the entity that pools money to purchase Innospec's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Hhg Plc2025-03-31
474.5 K
Nuveen Asset Management, Llc2024-12-31
471.1 K
Nuveen, Llc2025-03-31
453.5 K
Financial Harvest, Llc2025-03-31
433.8 K
Westwood Holdings Group Inc2025-03-31
382.4 K
Charles Schwab Investment Management Inc2025-03-31
354.7 K
Brown Advisory Holdings Inc2025-03-31
329.4 K
Northern Trust Corp2025-03-31
318.3 K
Jpmorgan Chase & Co2025-03-31
273 K
Blackrock Inc2025-03-31
3.7 M
Vanguard Group Inc2025-03-31
3.2 M
Note, although Innospec's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Innospec's market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.07 B.

Market Cap

1.61 Billion

Project Innospec's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets 0.03  0.03 
Return On Capital Employed 0.13  0.10 
Return On Assets 0.02  0.02 
Return On Equity 0.03  0.03 
The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.1 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.1.
When accessing Innospec's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Innospec's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Innospec's profitability and make more informed investment decisions.

Evaluate Innospec's management efficiency

As of 07/21/2025, Return On Tangible Assets is likely to drop to 0.03. In addition to that, Return On Capital Employed is likely to drop to 0.1. At this time, Innospec's Non Current Liabilities Total is relatively stable compared to the past year. As of 07/21/2025, Change To Liabilities is likely to grow to about 78.1 M, while Total Current Liabilities is likely to drop slightly above 240.4 M. Innospec's management efficiency ratios could be used to measure how well Innospec manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 48.78  51.22 
Tangible Book Value Per Share 30.81  32.35 
Enterprise Value Over EBITDA 11.13  5.93 
Price Book Value Ratio 2.27  1.33 
Enterprise Value Multiple 11.13  5.93 
Price Fair Value 2.27  1.33 
Enterprise Value1.7 B1.7 B
Leadership at Innospec emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Enterprise Value Revenue
1.0172
Revenue
1.8 B
Quarterly Revenue Growth
(0.12)
Revenue Per Share
71.58
Return On Equity
0.022
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Innospec insiders, such as employees or executives, is commonly permitted as long as it does not rely on Innospec's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Innospec insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Patrick Williams over three weeks ago
Acquisition by Patrick Williams of 30292 shares of Innospec subject to Rule 16b-3
 
Corbin Barnes over two months ago
Disposition of 740 shares by Corbin Barnes of Innospec at 91.53 subject to Rule 16b-3
 
Parrette Leslie J over three months ago
Acquisition by Parrette Leslie J of 189 shares of Innospec at 131.57 subject to Rule 16b-3
 
Corbin Barnes over three months ago
Disposition of 598 shares by Corbin Barnes of Innospec at 99.68 subject to Rule 16b-3
 
Blackmore Milton C over three months ago
Disposition of 652 shares by Blackmore Milton C of Innospec at 103.3012 subject to Rule 16b-3
 
Patrick Williams over three months ago
Disposition of 1318 shares by Patrick Williams of Innospec at 123.96 subject to Rule 16b-3
 
Blackmore Milton C over six months ago
Disposition of 1035 shares by Blackmore Milton C of Innospec at 43.95 subject to Rule 16b-3
 
Poccia Claudia over six months ago
Disposition of 300 shares by Poccia Claudia of Innospec at 99.85 subject to Rule 16b-3
 
Blackmore Milton C over six months ago
Disposition of 1035 shares by Blackmore Milton C of Innospec at 43.95 subject to Rule 16b-3
 
Patrick Williams over six months ago
Disposition of 2757 shares by Patrick Williams of Innospec at 123.6337 subject to Rule 16b-3
 
Ian Cleminson over six months ago
Disposition of 311 shares by Ian Cleminson of Innospec at 99.85 subject to Rule 16b-3
 
Ian Cleminson over six months ago
Acquisition by Ian Cleminson of 450 shares of Innospec at 95.7 subject to Rule 16b-3

Innospec Corporate Filings

30th of May 2025
Other Reports
ViewVerify
F4
15th of May 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
14th of May 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13th of May 2025
Other Reports
ViewVerify
Innospec time-series forecasting models is one of many Innospec's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Innospec's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Innospec Earnings Estimation Breakdown

The calculation of Innospec's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Innospec is estimated to be 1.37 with the future projection ranging from a low of 1.3375 to a high of 1.4025. Please be aware that this consensus of annual earnings estimates for Innospec is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.0
1.34
Lowest
Expected EPS
1.37
1.40
Highest

Innospec Earnings Projection Consensus

Suppose the current estimates of Innospec's value are higher than the current market price of the Innospec stock. In this case, investors may conclude that Innospec is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Innospec's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2025Current EPS (TTM)
285.93%
0.0
1.37
1.08

Innospec Earnings History

Earnings estimate consensus by Innospec analysts from Wall Street is used by the market to judge Innospec's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Innospec's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Innospec Quarterly Gross Profit

125.1 Million

At this time, Innospec's Retained Earnings are relatively stable compared to the past year. As of 07/21/2025, Price Earnings Ratio is likely to grow to 80.93, while Retained Earnings Total Equity is likely to drop slightly above 628.1 M. As of 07/21/2025, Net Income Applicable To Common Shares is likely to grow to about 160.6 M, while Common Stock Shares Outstanding is likely to drop slightly above 20.1 M.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Innospec's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
81.5582.9884.41
Details
Intrinsic
Valuation
LowRealHigh
74.72100.13101.56
Details
Naive
Forecast
LowNextHigh
79.0680.4981.92
Details
2 Analysts
Consensus
LowTargetHigh
104.65115.00127.65
Details
Note that many institutional investors and large investment bankers can move markets due to the volume of Innospec assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Innospec. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Innospec's stock price in the short term.

Innospec Earnings per Share Projection vs Actual

Actual Earning per Share of Innospec refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Innospec predict the company's earnings will be in the future. The higher the earnings per share of Innospec, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Innospec Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Innospec, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Innospec should always be considered in relation to other companies to make a more educated investment decision.

Innospec Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Innospec's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
null
nullnullnullnull
null
nullnullnullnull
2025-05-07
2025-03-311.41671.420.0033
2025-02-11
2024-12-311.361.410.05
2024-11-05
2024-09-301.351.350.0
2024-08-06
2024-06-301.371.390.02
2024-05-09
2024-03-311.641.750.11
2024-02-13
2023-12-311.621.840.2213 
2023-11-07
2023-09-301.451.590.14
2023-08-08
2023-06-301.281.280.0
2023-05-03
2023-03-311.171.380.2117 
2023-02-21
2022-12-311.41.2-0.214 
2022-11-08
2022-09-301.411.740.3323 
2022-08-02
2022-06-301.361.580.2216 
2022-05-03
2022-03-311.191.530.3428 
2022-02-15
2021-12-311.041.30.2625 
2021-11-02
2021-09-301.011.150.1413 
2021-08-03
2021-06-300.891.30.4146 
2021-05-04
2021-03-310.991.060.07
2021-02-16
2020-12-310.711.270.5678 
2020-11-04
2020-09-300.340.710.37108 
2020-08-04
2020-06-300.2-0.18-0.38190 
2020-05-05
2020-03-311.231.420.1915 
2020-02-18
2019-12-311.371.470.1
2019-11-05
2019-09-301.251.40.1512 
2019-08-06
2019-06-301.11.120.02
2019-05-07
2019-03-311.191.250.06
2019-02-19
2018-12-311.371.620.2518 
2018-11-06
2018-09-301.061.20.1413 
2018-08-07
2018-06-301.051.0-0.05
2018-05-08
2018-03-310.911.020.1112 
2018-02-13
2017-12-311.211.470.2621 
2017-11-07
2017-09-300.921.00.08
2017-08-08
2017-06-301.091.160.07
2017-05-09
2017-03-310.861.00.1416 
2017-02-14
2016-12-310.891.090.222 
2016-11-02
2016-09-300.770.780.01
2016-08-02
2016-06-300.881.030.1517 
2016-05-03
2016-03-310.770.930.1620 
2016-02-16
2015-12-311.021.240.2221 
2015-11-03
2015-09-300.871.180.3135 
2015-08-04
2015-06-300.731.020.2939 
2015-05-05
2015-03-310.840.910.07
2015-02-17
2014-12-310.881.160.2831 
2014-11-04
2014-09-300.750.770.02
2014-08-05
2014-06-300.680.770.0913 
2014-05-06
2014-03-310.670.54-0.1319 
2014-02-12
2013-12-310.961.060.110 
2013-11-05
2013-09-300.830.65-0.1821 
2013-08-07
2013-06-300.680.750.0710 
2013-05-06
2013-03-310.850.72-0.1315 
2013-02-12
2012-12-310.860.890.03
2012-10-31
2012-09-300.750.65-0.113 
2012-08-08
2012-06-300.790.790.0
2012-05-07
2012-03-310.731.00.2736 
2012-02-14
2011-12-310.880.970.0910 
2011-11-01
2011-09-300.780.930.1519 
2011-08-08
2011-06-300.730.850.1216 
2010-08-03
2010-06-300.260.270.01
2010-02-16
2009-12-31-0.26-0.010.2596 
2009-10-29
2009-09-300.2-0.11-0.31155 
2009-08-04
2009-06-300.060.120.06100 
2009-05-06
2009-03-310.230.260.0313 
2009-02-19
2008-12-310.240.22-0.02
2008-10-30
2008-09-300.240.21-0.0312 
2008-07-30
2008-06-300.40.07-0.3382 
2008-04-30
2008-03-310.330.340.01
2008-02-07
2007-12-310.280.450.1760 
2007-10-31
2007-09-300.290.23-0.0620 
2007-08-01
2007-06-300.240.270.0312 
2007-05-02
2007-03-310.230.240.01
2007-02-07
2006-12-310.02-0.03-0.05250 
2006-11-01
2006-09-30-0.110.140.25227 
2006-07-26
2006-06-30-0.040.040.08200 
2006-04-24
2006-03-31-0.090.030.12133 
2006-02-06
2005-12-31-0.23-0.31-0.0834 
2005-10-24
2005-09-30-0.24-0.210.0312 
2005-07-25
2005-06-30-0.26-4.23-3.971526 
2005-04-25
2005-03-31-0.19-0.090.152 
2005-02-07
2004-12-31-0.55-0.540.01
2004-10-25
2004-09-30-0.010.350.363600 
2004-07-26
2004-06-300.470.13-0.3472 
2004-04-26
2004-03-310.490.28-0.2142 
2003-10-27
2003-09-300.610.720.1118 
2003-07-28
2003-06-300.570.52-0.05
2003-04-28
2003-03-310.60.46-0.1423 
2003-02-10
2002-12-310.70.6-0.114 
2002-10-28
2002-09-300.720.720.0
2002-07-29
2002-06-300.730.7-0.03
2002-04-29
2002-03-310.660.740.0812 
2002-02-12
2001-12-310.140.160.0214 
2001-10-29
2001-09-300.120.140.0216 
2001-07-27
2001-06-300.140.330.19135 
2001-04-30
2001-03-310.080.06-0.0225 
2001-02-12
2000-12-310.230.280.0521 
2000-10-26
2000-09-300.250.16-0.0936 
2000-07-27
2000-06-300.170.16-0.01
2000-05-02
2000-03-310.220.12-0.145 
2000-02-10
1999-12-310.380.29-0.0923 
1999-10-28
1999-09-300.40.440.0410 
1999-07-29
1999-06-300.430.41-0.02
1999-04-29
1999-03-310.530.37-0.1630 
1999-02-09
1998-12-310.480.510.03
1998-11-02
1998-09-300.460.37-0.0919 
1998-07-27
1998-06-300.60.57-0.03

Innospec Corporate Management

David CPAGeneral VPProfile
Trey GriffinSenior ResourcesProfile
Graeme BlairHead FinanceProfile
Corbin BarnesSenior RelationsProfile

Additional Tools for Innospec Stock Analysis

When running Innospec's price analysis, check to measure Innospec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innospec is operating at the current time. Most of Innospec's value examination focuses on studying past and present price action to predict the probability of Innospec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innospec's price. Additionally, you may evaluate how the addition of Innospec to your portfolios can decrease your overall portfolio volatility.